Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC. | Cell Death Dis | 2022 | 36167821 | PubTator, text mining | PubMed |
| Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma. | Front Oncol | 2022 | 36158685 | PubTator, text mining | PubMed |
| Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein-Barr Virus Infection. | Curr Oncol | 2022 | 36135044 | PubTator, text mining | PubMed |
| Molecular pathways in glioblastoma-derived stem cells to identify effective drug agents: A bioinformatics study. | J Family Med Prim Care | 2022 | 36119333 | PubTator, text mining | PubMed |
| Specific classification and new therapeutic targets for neuroendocrine prostate cancer: A patient-based, diagnostic study. | Front Genet | 2022 | 36118857 | PubTator, text mining | PubMed |
| Malnourishment affects gene expression along the length of the small intestine. | Front Nutr | 2022 | 36118759 | PubTator, text mining | PubMed |
| CD36 deficiency inhibits proliferation by cell cycle control in skeletal muscle cells. | Front Physiol | 2022 | 36111143 | PubTator, text mining | PubMed |
| Structural, enzymatic and spatiotemporal regulation of PP2A-B55 phosphatase in the control of mitosis. | Front Cell Dev Biol | 2022 | 36105360 | PubTator, text mining | PubMed |
| Hierarchical identification of a transcriptional panel for the histological diagnosis of lung neuroendocrine tumors. | Front Genet | 2022 | 36105102 | PubTator, text mining | PubMed |
| NudCD1 as a prognostic marker in colorectal cancer and its role in the upregulation of cellular spindle assembly checkpoint genes and LIS1 pathways. | BMC Cancer | 2022 | 36104662 | PubTator, text mining | PubMed |
| Integrated Analysis of the lncRNA-Associated ceRNA Network in Wilms Tumor via TARGET and GEO Databases. | Genet Res (Camb) | 2022 | 36101743 | PubTator, text mining | PubMed |
| Identifying General Tumor and Specific Lung Cancer Biomarkers by Transcriptomic Analysis. | Biology (Basel) | 2022 | 36101460 | PubTator, text mining | PubMed |
| The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation. | Transl Cancer Res | 2022 | 36093542 | PubTator, text mining | PubMed |
| Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma. | Front Cell Dev Biol | 2022 | 36092720 | PubTator, text mining | PubMed |
| Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds. | Heliyon | 2022 | 36091949 | PubTator, text mining | PubMed |
| Identify metabolism-related genes IDO1, ALDH2, NCOA2, SLC7A5, SLC3A2, LDHB, and HPRT1 as potential prognostic markers and correlate with immune infiltrates in head and neck squamous cell carcinoma. | Front Immunol | 2022 | 36090994 | PubTator, text mining | PubMed |
| Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker. | J Oncol | 2022 | 36090896 | PubTator, text mining | PubMed |
| Transcriptome analysis of Homo sapiens and Mus musculus reveals mechanisms of CD8+ T cell exhaustion caused by different factors. | PLoS One | 2022 | 36084049 | PubTator, text mining | PubMed |
| Dysregulation of Pseudogenes/lncRNA-Hsa-miR-1-3p-PAICS Pathway Promotes the Development of NSCLC. | J Oncol | 2022 | 36081668 | PubTator, text mining | PubMed |
| DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36077818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=30